Related Experiment Video
Updated: Jan 16, 2026

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
Imaging myocardial scar in hypertrophic cardiomyopathy: advances in CMR and CT
Matteo Sclafani1,2, Chiara Perrotti2, Luigi Salerno2
1Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Insights
Myocardial scarring in hypertrophic cardiomyopathy (HCM) drives adverse outcomes. Advanced imaging like cardiovascular magnetic resonance (CMR) and cardiac computed tomography (CT) are vital for assessing this scar and guiding patient management.
Area of Science:
- Cardiology
- Medical Imaging
Background:
- Myocardial scarring is a key feature of hypertrophic cardiomyopathy (HCM), contributing to adverse events like sudden cardiac death and heart failure.
- The fibrotic tissue in HCM is complex, involving replacement and interstitial fibrosis, often with myocardial disarray.
Purpose of the Study:
- To review the role of multimodality cardiovascular imaging in assessing myocardial scar in HCM.
- To focus on cardiovascular magnetic resonance (CMR) and cardiac computed tomography (CT) for scar characterization and discuss their clinical implications.
Main Methods:
- Cardiovascular magnetic resonance (CMR) techniques including late gadolinium enhancement, T1/T2 mapping, and diffusion tensor imaging.
- Cardiac computed tomography (CT) methods such as delayed iodine enhancement and CT-derived extracellular volume mapping.
Main Results:
- CMR is the established gold standard for non-invasive fibrosis assessment in HCM, offering detailed scar insights.
- CT is an emerging modality providing valuable scar assessment, especially when CMR is not feasible.
Conclusions:
- Multimodality imaging, particularly CMR and CT, is crucial for characterizing myocardial scar in HCM.
- Accurate scar assessment aids in risk stratification and personalized management strategies for HCM patients.
Abstract:
Myocardial scarring is a hallmark of hypertrophic cardiomyopathy (HCM) and a major driver of adverse outcomes, including sudden cardiac death and heart failure progression. The fibrotic substrate in HCM is complex, encompassing both replacement and interstitial fibrosis, often accompanied by myocardial disarray. Advanced cardiovascular imaging enables detailed scar characterization, which is crucial for risk stratification and personalized management. Cardiovascular magnetic resonance (CMR) is the gold standard for non-invasive fibrosis assessment. Techniques such as late gadolinium enhancement, myocardial mapping of T1 and T2 relaxation properties, and diffusion tensor imaging provide complementary insights into scar burden and architecture. Cardiac computed tomography (CT) is an emerging modality with increasing clinical relevance. Delayed iodine enhancement and CT-derived extracellular volume mapping offer a valuable alternative for scar assessment, particularly when CMR is contraindicated. This review highlights the role of multimodality imaging in assessing myocardial scar in HCM, with a focus on CMR and CT, and explores their clinical implications.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System V: CT
Mitral Stenosis II: Clinical features and Diagnostic Tests
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Cardiomyopathy IV: Restrictive Cardiomyopathy

